SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                      -----------------------------------


                                    FORM 8-K


                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the

                        Securities Exchange Act of 1934


       Date of Report (Date of earliest event reported): January 5, 2000



                              OCEAN BIO-CHEM, INC.

               (Exact name of registrant as specified in charter)

                           FLORIDA 2-7019759-1564329
       (State or other jurisdiction(Commission File Number)(IRS Employer
                     of Incorporation) Identification No.)


              4041 S. W. 47 AVENUE, FORT LAUDERDALE, FLORIDA 33314
              (Address of principal executive offices) (Zip Code)

        Registrant's telephone number, including area code: 954/587-6280









ITEM 4.  CHANGES  IN  REGISTRANT'S  CERTIFYING  ACCOUNTANT  (a) The  independent
certified public accounting firm for Registrant,  Infante,  Lago & Company,  has
been  dismissed due to the departure of Jesus A. Lago,  the partner in charge of
the Registrant's  audit. The dismissal was necessary in order for the Registrant
to retain Berkovits & Company,  P.A. as the Registrant's  independent  certified
public  accountants  in which  Mr.  Jesus  A.  Lago has  become a  partner.  The
dismissal was  effective  January 5, 2000.  (b) (i) Infante,  Lago & Company was
dismissed   solely  because  of  the  resignation  of  the  individual   partner
responsible  for the  Registrant's  audit.  (ii)  The  report  on the  financial
statements of the Registrant by Infante,  Lago & Company over the past two years
contain no adverse  opinion or  disclaimer  of opinion and was not  qualified or
modified as to  uncertainty,  audit scope or  accounting  principles.  (iii) The
decision to change  accountants  was  approved by the Board of  Directors of the
Registrant.  (iv)  During  Registrant's  two most  recent  fiscal  years and any
subsequent  interim  period  preceding the dismissal of Infante,  Lago & Company
there  were no  disagreements  with  Infante,  Lago & Company  on any  matter of
accounting principles or practices, financial statements, disclosure or auditing
scope or procedure. (v) No events referred to in Item 304(a)(v) of Regulation SK
occurred during the two years prior to the dismissal of Infante, Lago & Company.
(2)  Berkovits  & Company,  P.A.  has been  engaged  effective  January 5, 2000.
Registrant  did not,  during the two most recent fiscal years or any  subsequent
interim period prior to engaging Berkovits & Company,  P.A., consult Berkovits &
Company, P.A. on any matter. (3) Registrant has provided Infante, Lago & Company
with a copy of the  foregoing  disclosures  and has  requested  Infante,  Lago &
Company to furnish the  Registrant  with a letter  addressed  to the  Commission
stating whether it agrees with the foregoing statements made by Registrant,  and
if not, stating the respects in which it does not agree.




Exhibit

Letter from Infante Lago and Company.

                                   SIGNATURES

Pursuant to the requirement of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                                  OCEAN BIO-CHEM, INC.


Date: January 10, 2000                            By: /S/ PETER G. DORNAU
- ----------------------                                    ----------------------

                                                  Name: Peter G. Dornau
                                                  Title: Chairman of the Board
                                                          of Directors and Chief
                                                          Executive Officer

Date: January 10, 2000                            By:/S/ EDWARD ANCHEL
- ----------------------                                   -----------------------

                                                  Name: Edward Anchel
                                                  Title: Chief Financial Officer